Navana Pharmaceuticals PLC (DSE: NAVANAPHAR)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
66.70
+0.40 (0.60%)
At close: Sep 12, 2024

Navana Pharmaceuticals Revenue

Navana Pharmaceuticals had revenue of 1.75B BDT in the quarter ending March 31, 2024, with 16.38% growth. This brings the company's revenue in the last twelve months to 6.50B, up 22.00% year-over-year. In the fiscal year ending June 30, 2023, Navana Pharmaceuticals had annual revenue of 5.71B with 19.91% growth.

Revenue (ttm)
6.50B
Revenue Growth
+22.00%
P/S Ratio
1.10
Revenue / Employee
1.57M
Employees
4,143
Market Cap
7.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20235.71B947.45M19.91%
Jun 30, 20224.76B1.15B31.95%
Jun 30, 20213.61B457.57M14.53%
Jun 30, 20203.15B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition